Catalog # |
Size |
Price |
|
---|---|---|---|
RK-001-01 | 125 tubes | $880 |
| I125-ACTH | ||||||||||||||||||||||
View/Download (PDF) - for reference only | |||||||||||||||||||||||
| Suggested Procedure | ||||||||||||||||||||||
| Recommended | ||||||||||||||||||||||
Data may differ slightly based on lot. | 65.1 pg/ml | ||||||||||||||||||||||
| 10 - 1280 pg/ml | ||||||||||||||||||||||
| |||||||||||||||||||||||
| Each kit contains 1.5 µCi of Iodine 125. | ||||||||||||||||||||||
| This package conforms to the 49 CFR173.421 for expected radioactive material limited quantity, N.O.S. UN2910. |
Effects of prolonged exendin-4 administration on hypothalamic-pituitary-adrenal axis activity and water balance.
Gil-lozano M, Romaní-pérez M, Outeiriño-iglesias V, et al. Am J Physiol Endocrinol Metab. 2013;304(10):E1105-17.
Cortisol, adrenocorticotropic hormone, serotonin, adrenaline and noradrenaline serum concentrations in relation to disease and stress in the horse.
Ayala I, Martos NF, Silvan G, Gutierrez-panizo C, Clavel JG, Illera JC. Res Vet Sci. 2012;93(1):103-7.
Obese carboxypeptidase E knockout mice exhibit multiple defects in peptide hormone processing contributing to low bone mineral density.
Cawley NX, Yanik T, Woronowicz A, Chang W, Marini JC, Loh YP. Am J Physiol Endocrinol Metab. 2010;299(2):E189-97.
Intermedin/Adrenomedullin-2 inhibits growth hormone release from cultured, primary anterior pituitary cells.
Taylor MM, Bagley SL, Samson WK. Endocrinology. 2006;147(2):859-64.
Central neuropeptide B administration activates stress hormone secretion and stimulates feeding in male rats.
Samson WK, Baker JR, Samson CK, Samson HW, Taylor MM. J Neuroendocrinol. 2004;16(10):842-9
Neuropeptide W acts in brain to control prolactin, corticosterone, and growth hormone release.
Baker JR, Cardinal K, Bober C, Taylor MM, Samson WK. Endocrinology. 2003;144(7):2816-21.
Social Network Confirmation